InflaRx N.V. (IFRX) stock
IFRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.15−0.03 (-2.54%)
Close on Nov 17, 2026Market cap $83.14MP/E –Yield –
InflaRx price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
InflaRx's price to sales ratio was 276.6× on Feb 27, 2026.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Feb 27, 2026 | 276.6× | −29.3 |
| 2025 | Dec 31, 2025 | 305.9× | – |
See a number that looks wrong?